As per the latest data by WHO, from the pandemic's onset until November 10, 2024, over 776.8 million confirmed COVID-19 cases ...

The majority of working-age patients with postacute sequelae of COVID-19/post-COVID-19 syndrome (PCS) do not recover ...

A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.

The use of electromagnetic navigation bronchoscopy (ENB)-guided microwave ablation (MWA) is safe and efficacy in treating patients with multiple bilateral pulmonary ground-glass opacities (GGOs). • ...

Respiratory illnesses, including COVID-19, influenza, and RSV, are surging across the United States, with healthcare systems ...

A compilation of recent news from the AHA and its Post-Acute Care Team, whose focus is to ensure post-acute care facilities', hospitals’ and health systems’ unique needs are national priorities.

An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose treatment has stopped working, according to scientists. Experts ...

We all know that calcium is important for strong bones and teeth, but could it also help decrease the risk of bowel cancer? According to new research funded by Cancer Research UK, consuming an ...

There may, of course, be individual variation in susceptibility to the acute toxic effects of the drug. The hypotension often encountered in meprobamate poisoning has been treated with intravenous ...